Dipeptidyl peptidase I in cultured fibroblasts in duchenne muscular dystrophy
Christine E. Sinclair BSc
Department of Neurochemistry and Muscular Dystrophy Group Research Laboratories, General Hospital, Newcastle upon Tyne, England
Search for more papers by this authorMarion S. Ecob PhD
Department of Neurochemistry and Muscular Dystrophy Group Research Laboratories, General Hospital, Newcastle upon Tyne, England
Search for more papers by this authorCorresponding Author
Dr. Ronald J. T. Pennincton DSc
Department of Neurochemistry and Muscular Dystrophy Group Research Laboratories, General Hospital, Newcastle upon Tyne, England
Neurochemistry Department, General Hospital, Westgate Road, Newcastle upon Tyne, NE4 6BE, EnglandSearch for more papers by this authorChristine E. Sinclair BSc
Department of Neurochemistry and Muscular Dystrophy Group Research Laboratories, General Hospital, Newcastle upon Tyne, England
Search for more papers by this authorMarion S. Ecob PhD
Department of Neurochemistry and Muscular Dystrophy Group Research Laboratories, General Hospital, Newcastle upon Tyne, England
Search for more papers by this authorCorresponding Author
Dr. Ronald J. T. Pennincton DSc
Department of Neurochemistry and Muscular Dystrophy Group Research Laboratories, General Hospital, Newcastle upon Tyne, England
Neurochemistry Department, General Hospital, Westgate Road, Newcastle upon Tyne, NE4 6BE, EnglandSearch for more papers by this authorAbstract
The specific activity of dipeptidyl peptidase I in cultured skin fibroblasts from patients with Duchenne muscular dystrophy did not differ significantly from that of controls.
References
- 1
Davis MH,
Gelman BB,
Grunstein E:
Decreased structure linked latency of lysosomal dipeptidyl aminopeptidase-I activity in Duchenne muscular dystrophy fibroblasts.
Neurology (Minneap)
32: 486–491
1977.
10.1212/WNL.32.5.486 Google Scholar
- 2 Davis MH, Pato CN, Grinvalsky H, Gruenstein E: Identification of a biochemical difference between male and female human fibroblasts. Implications for the expression of Duchenne muscular dystrophy. Neurology (NY) 32: 951–957 1982.
- 3 Gelman BB, Davis MH, Morris RE, Grunstein E: Structural changes in lysosomes from cultured human fibroblasts in Duchenne's muscular dystrophy. J Cell Biol 88: 329–337 1982.
- 4 Gelman BB, Papa L, Davis MH, Grunstein E: Decreased lysosomal dipeptidyl aminopeptidase I activity in cultured human skin fibroblasts in Duchenne's muscular dystrophy. J Clin Invest 65: 1398–1406 1980.
- 5 Ionasescu V, Lara-Braud C, Zellweger H, Ionasescu R, Burmeister L: Fibroblast cultures in Duchenne muscular dystrophy. Acta Neurol Scand 55: 407–417 1977.
- 6 Jones GE, Witkowski JA: Reduced adhesiveness between skin fibroblasts from patients with Duchenne muscular dystrophy. J Neurol Sci 43: 465–470 1979.
- 7 Kent C: Increased rate of cell—substratum detachment of fibroblasts from patients with Duchenne muscular dystrophy. Proc Natl Acad Sci USA 80: 3086–3090 1983.
- 8 Liechti-Gallati S, Moser H, Siegrist HP, Wiesman U, Herschkowitz NN: Abnormal growth kinetics and 5′-nucleotidase activities in cultured skin fibroblasts from patients with Duchenne muscular dystrophy. Pediatr Res 15: 1411–1414 1981.
- 9 McDonald JK, Zeitman BB, Reilly TJ, Ellis S: New observations on the substrate specificity of cathepsin C (dipeptidyl aminopeptidase I). J Biol Chem 244: 2693–2709 1969.
- 10 Peterson GL: A simplification of the protein assay method of Lowry et al. which is more generally applicable. Anal Biochem 83: 346–356 1977.
- 11 Thompson RG, Nickel B, Finlayson S, Meuser R, Hamerton JL, Wrogemann K: 56K Fibroblast protein not specific for Duchenne muscular dystrophy but for skin biopsy site. Nature 304: 740–741 1983.
- 12 Thompson RG, Sponder ES, Rosenmann E, Hamerton JL, Wrogemann K: Proline incorporation by cultured skin fibroblasts from patients with Duchenne muscular dys trophy. J Neurol Sci 57: 41–54 1982.
